Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-04

Clinical Trial Update: Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women [Phase 1]

View source ↗

Summary

Phase 1 trial investigating isoflavones to promote calcium absorption and prevent bone loss in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoflavones (isoflavones)

Snippet

Sponsor: Purdue University | Conditions: Osteoporosis, Osteopenia | Phase 1 | Status: COMPLETED